The University of Chicago Header Logo

Connection

Tamar Polonsky to Humans

Back to Details
This is a "connection" page, showing publications Tamar Polonsky has written about Humans.
Tamar Polonsky
Connection Strength
1.050
Humans
  1. Management of Patients With Chronic Coronary Disease. JAMA. 2024 08 20; 332(7):585-586.
    View in: PubMed
    Score: 0.028
  2. Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease. J Vasc Surg. 2024 Apr; 79(4):893-903.
    View in: PubMed
    Score: 0.027
  3. Menstrual Cycle Irregularity in Adolescence Is Associated With Cardiometabolic Health in Early Adulthood. J Am Heart Assoc. 2023 09 19; 12(18):e029372.
    View in: PubMed
    Score: 0.026
  4. Highlights in ASCVD Primary Prevention for 2021. J Am Heart Assoc. 2022 07 05; 11(13):e025973.
    View in: PubMed
    Score: 0.024
  5. 40 Years of Research on Coronary Artery Calcium and Still No Convincing Clinical Trials? JACC Cardiovasc Imaging. 2022 05; 15(5):856-858.
    View in: PubMed
    Score: 0.024
  6. Extra Coronary Calcium: Should We Measure All That Meets the Eye? Circ Cardiovasc Imaging. 2022 03; 15(3):e013937.
    View in: PubMed
    Score: 0.024
  7. Finding the Right Age for CAC Testing: How Low Should You Go? J Am Coll Cardiol. 2021 10 19; 78(16):1584-1586.
    View in: PubMed
    Score: 0.023
  8. Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. J Am Heart Assoc. 2021 06 15; 10(12):e017609.
    View in: PubMed
    Score: 0.023
  9. Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review. JAMA. 2021 Jun 01; 325(21):2188-2198.
    View in: PubMed
    Score: 0.023
  10. Heart Failure and Changes in Kidney Function: Focus on Understanding, Not Reacting. Heart Fail Clin. 2019 Oct; 15(4):455-461.
    View in: PubMed
    Score: 0.020
  11. Associations of Weight Change With Changes in Calf Muscle Characteristics and Functional Decline in Peripheral Artery Disease. J Am Heart Assoc. 2019 07 02; 8(13):e010890.
    View in: PubMed
    Score: 0.020
  12. Risk factors for chemotherapy-related cardiac toxicity. Curr Opin Cardiol. 2019 05; 34(3):283-288.
    View in: PubMed
    Score: 0.020
  13. Coronary Artery Calcium in Individuals With Severe Mental Illness. Circ Cardiovasc Imaging. 2019 03; 12(3):e008861.
    View in: PubMed
    Score: 0.019
  14. Durability of Benefits From Supervised Treadmill Exercise in People With Peripheral Artery Disease. J Am Heart Assoc. 2019 01 08; 8(1):e009380.
    View in: PubMed
    Score: 0.019
  15. Ambulatory Blood Pressure Monitoring. JAMA. 2018 Nov 06; 320(17):1807-1808.
    View in: PubMed
    Score: 0.019
  16. Viewing the Value of Coronary Artery Calcium Testing From Different Perspectives. JAMA Cardiol. 2018 10 01; 3(10):908-910.
    View in: PubMed
    Score: 0.019
  17. Presence of Diabetes Does Not Mandate Lower Blood Pressure to Reduce Cardiovascular Events. J Am Coll Cardiol. 2018 09 11; 72(11):1224-1226.
    View in: PubMed
    Score: 0.019
  18. Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York. JAMA Cardiol. 2017 06 01; 2(6):627-634.
    View in: PubMed
    Score: 0.017
  19. Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Mar 20; 6(3).
    View in: PubMed
    Score: 0.017
  20. Breast Arterial Calcification: Expanding the Reach of Cardiovascular Prevention. Circulation. 2017 02 07; 135(6):499-501.
    View in: PubMed
    Score: 0.017
  21. Home-Based Exercise: A Therapeutic Option for Peripheral Artery Disease. Circulation. 2016 10 18; 134(16):1127-1129.
    View in: PubMed
    Score: 0.016
  22. Treatment of Patients With Stable Ischemic Heart Disease--Reply. JAMA. 2016 May 03; 315(17):1906-7.
    View in: PubMed
    Score: 0.016
  23. Exercise Treadmill Testing. JAMA. 2015 Nov 10; 314(18):1968-9.
    View in: PubMed
    Score: 0.015
  24. High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics. Atherosclerosis. 2014 Nov; 237(1):169-76.
    View in: PubMed
    Score: 0.014
  25. Coronary artery calcium score. JAMA. 2014 Aug 27; 312(8):837-8.
    View in: PubMed
    Score: 0.014
  26. Coronary artery calcium scores using nongated computed tomography: what to do with incidental results? Circ Cardiovasc Imaging. 2013 Jul; 6(4):494-5.
    View in: PubMed
    Score: 0.013
  27. CVD screening in low-risk, asymptomatic adults: clinical trials needed. Nat Rev Cardiol. 2012 10; 9(10):599-604.
    View in: PubMed
    Score: 0.012
  28. Chronic kidney disease: a coronary heart disease equivalent? Lancet. 2012 Sep 01; 380(9844):783-5.
    View in: PubMed
    Score: 0.012
  29. Coronary artery calcium testing: dos and don'ts. Cardiol Clin. 2012 Feb; 30(1):49-55.
    View in: PubMed
    Score: 0.012
  30. Time for a policy change for coronary artery calcium testing in asymptomatic people? J Am Coll Cardiol. 2011 Oct 11; 58(16):1702-4.
    View in: PubMed
    Score: 0.012
  31. The contribution of early nephropathy to cardiovascular risk. Cardiol Clin. 2010 Aug; 28(3):427-36.
    View in: PubMed
    Score: 0.011
  32. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010 Apr 28; 303(16):1610-6.
    View in: PubMed
    Score: 0.010
  33. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis. 2009 Dec; 207(2):440-4.
    View in: PubMed
    Score: 0.010
  34. The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus. Trends Cardiovasc Med. 2009 Apr; 19(3):94-9.
    View in: PubMed
    Score: 0.010
  35. Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy. Am J Cardiol. 2008 Apr 17; 101(8A):27B-35B.
    View in: PubMed
    Score: 0.009
  36. Nocturnal Oxygen Therapy for Central Sleep Apnea in Patients with Heart Failure: A Multisite, Double-Blind, Sham-controlled Randomized Clinical Trial (LOFT-HF). Ann Am Thorac Soc. 2025 Dec; 22(12):1951-1960.
    View in: PubMed
    Score: 0.008
  37. Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia: A Secondary Analysis of the MINT Randomized Clinical Trial. JAMA Intern Med. 2025 Aug 01; 185(8):947-954.
    View in: PubMed
    Score: 0.008
  38. Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trial. Contemp Clin Trials. 2025 Sep; 156:108030.
    View in: PubMed
    Score: 0.008
  39. Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia. Am Heart J. 2025 Apr; 282:146-155.
    View in: PubMed
    Score: 0.007
  40. Hepatocyte growth factor for walking performance in peripheral artery disease. J Vasc Surg. 2025 Jun; 81(6):1467-1478.e1.
    View in: PubMed
    Score: 0.007
  41. The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease. Vasc Med. 2024 12; 29(6):640-652.
    View in: PubMed
    Score: 0.007
  42. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 01; 9(9):808-816.
    View in: PubMed
    Score: 0.007
  43. Differing associations of PM2.5 exposure with systolic and diastolic blood pressures across exposure durations in a predominantly non-Hispanic Black cohort. Sci Rep. 2024 08 31; 14(1):20256.
    View in: PubMed
    Score: 0.007
  44. Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial. Circulation. 2024 Dec 03; 150(23):1826-1836.
    View in: PubMed
    Score: 0.007
  45. Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial. BMJ Open. 2024 08 07; 14(8):e078197.
    View in: PubMed
    Score: 0.007
  46. Contextual Deprivation, Race and Ethnicity, and Income in Air Pollution and Cardiovascular Disease. JAMA Netw Open. 2024 08 01; 7(8):e2429137.
    View in: PubMed
    Score: 0.007
  47. Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2024 Jun 03; 31(8):1048-1054.
    View in: PubMed
    Score: 0.007
  48. PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment. Circ Cardiovasc Qual Outcomes. 2024 Apr; 17(4):e010763.
    View in: PubMed
    Score: 0.007
  49. Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e026921.
    View in: PubMed
    Score: 0.007
  50. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial. Diabetes Care. 2024 Jan 01; 47(1):81-88.
    View in: PubMed
    Score: 0.007
  51. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia. N Engl J Med. 2023 12 28; 389(26):2446-2456.
    View in: PubMed
    Score: 0.007
  52. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2023 11 01; 8(11):1061-1069.
    View in: PubMed
    Score: 0.007
  53. The Role of Health Insurance Type and Clinic Visit on Hypertension Status Among Multiethnic Chicago Residents. Am J Health Promot. 2024 03; 38(3):306-315.
    View in: PubMed
    Score: 0.007
  54. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors. J Am Heart Assoc. 2023 10 17; 12(20):e030385.
    View in: PubMed
    Score: 0.007
  55. Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis. JAMA Netw Open. 2023 09 05; 6(9):e2334590.
    View in: PubMed
    Score: 0.007
  56. Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial. J Am Heart Assoc. 2023 09 05; 12(17):e031182.
    View in: PubMed
    Score: 0.007
  57. Hospitalizations during home-based walking exercise interventions in peripheral artery disease: Results from two randomized clinical trials. Vasc Med. 2023 12; 28(6):583-585.
    View in: PubMed
    Score: 0.007
  58. Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE Study. J Am Heart Assoc. 2023 07 04; 12(13):e027899.
    View in: PubMed
    Score: 0.007
  59. Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE. Am Heart J. 2023 10; 264:31-39.
    View in: PubMed
    Score: 0.007
  60. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale. J Am Geriatr Soc. 2023 06; 71(6):1701-1713.
    View in: PubMed
    Score: 0.006
  61. Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study. Vasc Med. 2023 04; 28(2):122-130.
    View in: PubMed
    Score: 0.006
  62. Seasonal variation in blood pressure control across US health systems. J Hypertens. 2023 05 01; 41(5):751-758.
    View in: PubMed
    Score: 0.006
  63. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory. Mayo Clin Proc. 2023 05; 98(5):662-675.
    View in: PubMed
    Score: 0.006
  64. Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021. Vasc Med. 2023 04; 28(2):144-146.
    View in: PubMed
    Score: 0.006
  65. Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial. JAMA. 2022 10 04; 328(13):1315-1325.
    View in: PubMed
    Score: 0.006
  66. Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg. 2023 Feb; 77(2):506-514.
    View in: PubMed
    Score: 0.006
  67. Urban Spatial Accessibility of Primary Care and Hypertension Control and Awareness on Chicago's South Side: A Study From the COMPASS Cohort. Circ Cardiovasc Qual Outcomes. 2022 09; 15(9):e008845.
    View in: PubMed
    Score: 0.006
  68. Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial. J Am Heart Assoc. 2022 08 02; 11(15):e025063.
    View in: PubMed
    Score: 0.006
  69. NT-pro B-type natriuretic peptide, early menopause, and incident heart failure in postmenopausal women of the ARIC study. Menopause. 2022 01 14; 29(3):309-316.
    View in: PubMed
    Score: 0.006
  70. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.
    View in: PubMed
    Score: 0.006
  71. Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-Analysis of Prospective Studies. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):741-749.
    View in: PubMed
    Score: 0.006
  72. Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial. Vasc Med. 2021 10; 26(5):497-506.
    View in: PubMed
    Score: 0.006
  73. Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial. JAMA. 2021 04 06; 325(13):1266-1276.
    View in: PubMed
    Score: 0.006
  74. Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial. Clin Trials. 2021 08; 18(4):449-456.
    View in: PubMed
    Score: 0.006
  75. High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study. Menopause. 2021 01 04; 28(3):284-291.
    View in: PubMed
    Score: 0.005
  76. Optimal Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Reduces Daytime Resting Heart Rate in Prediabetes: A Randomized Controlled Study. J Am Heart Assoc. 2020 10 20; 9(19):e016871.
    View in: PubMed
    Score: 0.005
  77. Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease. Exp Gerontol. 2020 10 15; 140:111048.
    View in: PubMed
    Score: 0.005
  78. Clinical characteristics and response to supervised exercise therapy of people with lower extremity peripheral artery disease. J Vasc Surg. 2021 02; 73(2):608-625.
    View in: PubMed
    Score: 0.005
  79. Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease. Vasc Med. 2020 08; 25(4):319-327.
    View in: PubMed
    Score: 0.005
  80. Meaningful change in 6-minute walk in people with peripheral artery disease. J Vasc Surg. 2021 01; 73(1):267-276.e1.
    View in: PubMed
    Score: 0.005
  81. Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy. J Am Heart Assoc. 2020 04 07; 9(7):e015197.
    View in: PubMed
    Score: 0.005
  82. Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial. Circ Res. 2020 02 28; 126(5):589-599.
    View in: PubMed
    Score: 0.005
  83. Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease. J Vasc Surg. 2020 03; 71(3):988-1001.
    View in: PubMed
    Score: 0.005
  84. Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association. Circulation. 2020 01 21; 141(3):e39-e53.
    View in: PubMed
    Score: 0.005
  85. Trends in Blood Pressure and High-Sensitivity Cardiac Troponin-T With Cardiovascular Disease: The Cardiovascular Health Study. Am J Hypertens. 2019 09 24; 32(10):1013-1020.
    View in: PubMed
    Score: 0.005
  86. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 12; 19(6):528-537.
    View in: PubMed
    Score: 0.005
  87. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Pharmacogenet Genomics. 2019 02; 29(2):31-38.
    View in: PubMed
    Score: 0.005
  88. Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. J Am Heart Assoc. 2019 01 22; 8(2):e011001.
    View in: PubMed
    Score: 0.005
  89. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):3210-3227.
    View in: PubMed
    Score: 0.005
  90. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1144-e1161.
    View in: PubMed
    Score: 0.005
  91. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018 10 23; 138(17):e595-e616.
    View in: PubMed
    Score: 0.005
  92. Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance. Vasc Med. 2018 08; 23(4):340-348.
    View in: PubMed
    Score: 0.005
  93. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial. JAMA. 2018 04 24; 319(16):1665-1676.
    View in: PubMed
    Score: 0.005
  94. A Novel Patient Recruitment Strategy: Patient Selection Directly from the Community through Linkage to Clinical Data. Appl Clin Inform. 2018 01; 9(1):114-121.
    View in: PubMed
    Score: 0.005
  95. Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. JAMA. 2017 12 05; 318(21):2089-2098.
    View in: PubMed
    Score: 0.004
  96. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 06; 71(6):e116-e135.
    View in: PubMed
    Score: 0.004
  97. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 05 15; 71(19):2176-2198.
    View in: PubMed
    Score: 0.004
  98. Femoral artery plaque characteristics, lower extremity collaterals, and mobility loss in peripheral artery disease. Vasc Med. 2017 12; 22(6):473-481.
    View in: PubMed
    Score: 0.004
  99. Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial. JAMA Cardiol. 2017 08 01; 2(8):902-907.
    View in: PubMed
    Score: 0.004
  100. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
    View in: PubMed
    Score: 0.004
  101. Racial differences in functional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017 09; 66(3):826-834.
    View in: PubMed
    Score: 0.004
  102. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program. Clin Pharmacol Ther. 2017 07; 102(1):106-114.
    View in: PubMed
    Score: 0.004
  103. Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events. JACC Cardiovasc Imaging. 2017 09; 10(9):1003-1012.
    View in: PubMed
    Score: 0.004
  104. Obesity and Cardiovascular Risk in Adults With Celiac Disease. J Clin Gastroenterol. 2016 08; 50(7):545-50.
    View in: PubMed
    Score: 0.004
  105. The Case For and Against a Coronary Artery Calcium Trial: Means, Motive, and Opportunity. JACC Cardiovasc Imaging. 2016 08; 9(8):994-1002.
    View in: PubMed
    Score: 0.004
  106. European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners Registry. Circulation. 2016 Jul 19; 134(3):201-11.
    View in: PubMed
    Score: 0.004
  107. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol. 2016 Jan 19; 67(2):139-147.
    View in: PubMed
    Score: 0.004
  108. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circulation. 2015 Sep 08; 132(10):916-22.
    View in: PubMed
    Score: 0.004
  109. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012 Aug 22; 308(8):788-95.
    View in: PubMed
    Score: 0.003
  110. Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power. Clin Trials. 2012 Apr; 9(2):232-46.
    View in: PubMed
    Score: 0.003
  111. Automated border detection for assessing the mechanical properties of the carotid arteries: comparison with carotid intima-media thickness. J Am Soc Echocardiogr. 2010 May; 23(5):567-72.
    View in: PubMed
    Score: 0.003
  112. Diagnostic value of parametric imaging of left ventricular wall motion from contrast-enhanced echocardiograms in patients with poor acoustic windows. J Am Soc Echocardiogr. 2009 Mar; 22(3):276-83.
    View in: PubMed
    Score: 0.002
  113. Use of carotid intima-media thickness to identify patients with ischemic stroke and transient ischemic attack with low yield of cardiovascular sources of embolus on transesophageal echocardiography. Stroke. 2008 Nov; 39(11):2969-74.
    View in: PubMed
    Score: 0.002
  114. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest. 2007 Apr; 131(4):964-71.
    View in: PubMed
    Score: 0.002
  115. Quantification of regional left ventricular wall motion from real-time 3-dimensional echocardiography in patients with poor acoustic windows: effects of contrast enhancement tested against cardiac magnetic resonance. J Am Soc Echocardiogr. 2006 Jul; 19(7):886-93.
    View in: PubMed
    Score: 0.002
  116. Developing a conceptual framework for understanding illness and attitudes in older, urban African Americans with diabetes. Diabetes Educ. 2000 May-Jun; 26(3):439-49.
    View in: PubMed
    Score: 0.001
  117. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology. 1995 Feb 01; 206(2):1108-16.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.